X4 Pharmaceuticals Inc. (XFOR)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Revenue	-	-	-	3.00M	-	3.50M	-	-	-
Cost of Revenue	2.00M	1.99M	1.89M	-	672.00K	103.00K	195.00K	300.00K	400.00K
Gross Profit	-2.00M	-1.99M	-1.89M	3.00M	-672.00K	3.40M	-195.00K	-300.00K	-400.00K
Operating Income	-107.52M	-87.57M	-85.11M	-59.87M	-51.70M	-45.88M	-36.13M	-24.35M	-14.82M
Interest Income	4.58M	219.00K	10.00K	273.00K	1.20M	809.00K	214.00K	-	-
Pretax Income	-101.09M	-93.84M	-88.68M	-61.98M	-52.81M	-43.02M	-33.88M	-22.98M	-13.22M
Net Income	-101.17M	-93.87M	-88.70M	-62.13M	-56.60M	-43.02M	-33.88M	-22.98M	-13.22M
Selling & General & Admin	35.51M	27.02M	24.70M	20.94M	17.64M	18.41M	8.01M	6.51M	2.12M
Research & Development	72.02M	61.06M	50.65M	41.93M	30.16M	30.98M	28.13M	17.83M	12.71M
Other Expenses	-	-6.27M	-3.57M	-2.11M	-1.10M	-85.00K	-16.00K	104.00K	-77.00K
Operating Expenses	107.52M	88.08M	75.35M	62.87M	47.80M	46.21M	32.27M	21.96M	12.67M
Interest Expense	5.78M	3.99M	3.64M	2.69M	2.15M	1.04M	2.08M	2.52M	472.00K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-
Cost & Expenses	107.52M	88.08M	75.35M	62.87M	47.80M	46.21M	32.27M	21.96M	12.67M
Income Tax	78.00K	28.00K	17.00K	148.00K	3.80M	3.90M	1.87M	2.62M	395.00K
Shares Outstanding (Basic)	177.81M	63.53M	25.75M	20.08M	11.53M	459.00K	343.64K	928.01K	928.01K
Shares Outstanding (Diluted)	177.81M	63.53M	25.75M	20.08M	11.53M	459.00K	343.64K	928.01K	928.01K
EPS (Basic)	-0.57	-1.48	-3.44	-3.09	-4.91	-93.73	-98.58	-24.76	-14.24
EPS (Diluted)	-0.57	-1.48	-3.44	-3.09	-4.91	-93.73	-98.58	-24.76	-14.24
EBITDA	-107.52M	-87.57M	-85.11M	-58.06M	-51.70M	-45.88M	-31.60M	-20.16M	-12.35M
Depreciation & Amortization	419.00K	1.99M	1.89M	1.23M	672.00K	103.00K	195.00K	300.00K	389.00K